Vilnius University Hospital Santaros Klinikos in Vilnius, Lithuania is a teaching hospital of the Vilnius University Faculty of Medicine. Santaros Klinikos is co-funded by the Lithuanian Ministry of Health and Vilnius University.

During the past decade, Rare diseases coordinating centre, Vilnius University Hospital Santaros klinikos conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Rare diseases coordinating centre, Vilnius University Hospital Santaros klinikos" are "Cardiac Rhabdomyoma" (1 trials), "Cortical Dysplasia" (1 trials), "Facial Angiofibroma" (1 trials), "Hematuria-Nephropathy-Deafness Syndrome" (1 trials) and "Hypomelanotic Macules" (1 trials). Many other conditions were trialed in "Rare diseases coordinating centre, Vilnius University Hospital Santaros klinikos" in a lesser frequency.

The vast majority of trials in "Rare diseases coordinating centre, Vilnius University Hospital Santaros klinikos" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Rare diseases coordinating centre, Vilnius University Hospital Santaros klinikos". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Rare diseases coordinating centre, Vilnius University Hospital Santaros klinikos, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Rare diseases coordinating centre, Vilnius University Hospital Santaros klinikos, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".